Content Click below to navigate through the document Company overview Financial review Conclusions Appendix References Q4 2023 Results Q4 2023 Results Investor presentation Investor pJreasneunatrayt 3io1n, 2024 January 31, 2024 Novartis Q4 Results | January 31, 2024 1 Content Disclaimer Click below to navigate through the document Company overview Financial review This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, t ...